Pulling Together: A 5-Year Plan to Improve Theranostic Outcomes by Improving the Accuracy of Dosimetry: An FNIH Joint Academic, Clinical, and Industrial Collaboration

Dale L. Bailey; John C. Dickson; Suzanne E. Lapi; Carlos Uribe; Clarita Saldarriaga Vargas; Price Jackson; Caroline Stokke; Julia Brosch-Lenz; Althea Lang; Stephen A. Graves; John J. Sunderland

doi:10.2967/jnumed.125.271665

Pulling Together: A 5-Year Plan to Improve Theranostic Outcomes by Improving the Accuracy of Dosimetry: An FNIH Joint Academic, Clinical, and Industrial Collaboration

Dale L. Bailey
, John C. Dickson
, Suzanne E. Lapi
, Carlos Uribe
, Clarita Saldarriaga Vargas
, Price Jackson
, Caroline Stokke
, Julia Brosch-Lenz
, Althea Lang
, Stephen A. Graves
, John J. Sunderland

RDA-TRNT

Research output › peer-review

Abstract

The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has recently launched the Precision Dosimetry Imaging Biomarker (PDIB) project, an international consortium-based initiative focused on solving the technical issues that currently limit the effective use of dosimetry-informed therapeutic radiation dosimetry. The PDIB project kicked off in April 2025—entirely funded by industry partners who see standardization and harmonization as both critical to the effective use of radiation dosimetry and laying firmly in the precompetitive space—and aims to enable reliable and reproducible standardized dosimetry of targeted radionuclide therapies. This work is expected to support the definition of absorbed dose toxicity limits for therapeutic radiopharmaceuticals as well as enable more accurate assessments of tumor absorbed dose.

Original language	English
Article number	271665
Pages (from-to)	1198-1200
Number of pages	3
Journal	Journal of Nuclear Medicine
Volume	67
Issue number	8
DOIs	https://doi.org/10.2967/jnumed.125.271665
State	Published - 3 Apr 2026

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.2967/jnumed.125.271665

Cite this

Bailey, D. L., Dickson, J. C., Lapi, S. E., Uribe, C., Saldarriaga Vargas, C., Jackson, P., Stokke, C., Brosch-Lenz, J., Lang, A., Graves, S. A., & Sunderland, J. J. (2026). Pulling Together: A 5-Year Plan to Improve Theranostic Outcomes by Improving the Accuracy of Dosimetry: An FNIH Joint Academic, Clinical, and Industrial Collaboration. Journal of Nuclear Medicine, 67(8), 1198-1200. Article 271665. https://doi.org/10.2967/jnumed.125.271665

@article{1d24984ce0684b02a0c9e76eab239eec,

title = "Pulling Together: A 5-Year Plan to Improve Theranostic Outcomes by Improving the Accuracy of Dosimetry: An FNIH Joint Academic, Clinical, and Industrial Collaboration",

abstract = "The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has recently launched the Precision Dosimetry Imaging Biomarker (PDIB) project, an international consortium-based initiative focused on solving the technical issues that currently limit the effective use of dosimetry-informed therapeutic radiation dosimetry. The PDIB project kicked off in April 2025{\textemdash}entirely funded by industry partners who see standardization and harmonization as both critical to the effective use of radiation dosimetry and laying firmly in the precompetitive space{\textemdash}and aims to enable reliable and reproducible standardized dosimetry of targeted radionuclide therapies. This work is expected to support the definition of absorbed dose toxicity limits for therapeutic radiopharmaceuticals as well as enable more accurate assessments of tumor absorbed dose.",

keywords = "Dosimetry, Stardardization, Gamma spectrometry, Activity measurements, Radiopharmaceutical therapy, Quantitatve imaging",

author = "Bailey, \{Dale L.\} and Dickson, \{John C.\} and Lapi, \{Suzanne E.\} and Carlos Uribe and \{Saldarriaga Vargas\}, Clarita and Price Jackson and Caroline Stokke and Julia Brosch-Lenz and Althea Lang and Graves, \{Stephen A.\} and Sunderland, \{John J.\}",

note = "Score=10",

year = "2026",

month = apr,

day = "3",

doi = "10.2967/jnumed.125.271665",

language = "English",

volume = "67",

pages = "1198--1200",

journal = "Journal of Nuclear Medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine Inc.",

number = "8",

}

Bailey, DL, Dickson, JC, Lapi, SE, Uribe, C, Saldarriaga Vargas, C, Jackson, P, Stokke, C, Brosch-Lenz, J, Lang, A, Graves, SA & Sunderland, JJ 2026, 'Pulling Together: A 5-Year Plan to Improve Theranostic Outcomes by Improving the Accuracy of Dosimetry: An FNIH Joint Academic, Clinical, and Industrial Collaboration', Journal of Nuclear Medicine, vol. 67, no. 8, 271665, pp. 1198-1200. https://doi.org/10.2967/jnumed.125.271665

TY - JOUR

T1 - Pulling Together: A 5-Year Plan to Improve Theranostic Outcomes by Improving the Accuracy of Dosimetry

T2 - An FNIH Joint Academic, Clinical, and Industrial Collaboration

AU - Bailey, Dale L.

AU - Dickson, John C.

AU - Lapi, Suzanne E.

AU - Uribe, Carlos

AU - Saldarriaga Vargas, Clarita

AU - Jackson, Price

AU - Stokke, Caroline

AU - Brosch-Lenz, Julia

AU - Lang, Althea

AU - Graves, Stephen A.

AU - Sunderland, John J.

N1 - Score=10

PY - 2026/4/3

Y1 - 2026/4/3

N2 - The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has recently launched the Precision Dosimetry Imaging Biomarker (PDIB) project, an international consortium-based initiative focused on solving the technical issues that currently limit the effective use of dosimetry-informed therapeutic radiation dosimetry. The PDIB project kicked off in April 2025—entirely funded by industry partners who see standardization and harmonization as both critical to the effective use of radiation dosimetry and laying firmly in the precompetitive space—and aims to enable reliable and reproducible standardized dosimetry of targeted radionuclide therapies. This work is expected to support the definition of absorbed dose toxicity limits for therapeutic radiopharmaceuticals as well as enable more accurate assessments of tumor absorbed dose.

AB - The Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium has recently launched the Precision Dosimetry Imaging Biomarker (PDIB) project, an international consortium-based initiative focused on solving the technical issues that currently limit the effective use of dosimetry-informed therapeutic radiation dosimetry. The PDIB project kicked off in April 2025—entirely funded by industry partners who see standardization and harmonization as both critical to the effective use of radiation dosimetry and laying firmly in the precompetitive space—and aims to enable reliable and reproducible standardized dosimetry of targeted radionuclide therapies. This work is expected to support the definition of absorbed dose toxicity limits for therapeutic radiopharmaceuticals as well as enable more accurate assessments of tumor absorbed dose.

KW - Dosimetry

KW - Stardardization

KW - Gamma spectrometry

KW - Activity measurements

KW - Radiopharmaceutical therapy

KW - Quantitatve imaging

UR - https://ecm.sckcen.be/OTCS/llisapi.dll/open/100406774

UR - https://www.scopus.com/pages/publications/105046497984

U2 - 10.2967/jnumed.125.271665

DO - 10.2967/jnumed.125.271665

M3 - Editorial

SN - 0161-5505

VL - 67

SP - 1198

EP - 1200

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

IS - 8

M1 - 271665

ER -